Clinical trial Recruiting at 1 site Observational Ages 0 Weeks to 40

Health outcomes of newborns from assisted reproductive technology

Official title: Prospective Cohort Study for Newborns From Patients Treated With ART in Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD)

Run by The First Affiliated Hospital of Zhengzhou University · NCT03993158 · Data updated 2026-11-12

This study looks at the health of babies born through assisted reproductive technology to see how it affects their short- and long-term well-being.

More Health Related Quality of Life trials

Quick facts

Study typeObservational
Ages0 Weeks to 40 Years
SexAll
Enrollment10000 (estimated)
SponsorThe First Affiliated Hospital of Zhengzhou University
Academic / other
Locations1 site (Zhengzhou, Henan)
StatusRecruiting
StartedJanuary 1, 2010
Main results expectedDecember 31, 2050
Study endsDecember 31, 2050
Registry record updatedMay 27, 2026
Trial IDNCT03993158 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are newborns from parents who have received ART treatment at the participating center.

Probably not a fit

Patients who have not undergone ART or whose newborns were not delivered at the participating center may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the short- and long-term health consequences for newborns born to parents who underwent assisted reproductive technology (ART) at the Reproductive Medical Center of the First Affiliated Hospital of Zhengzhou University. The study utilizes a comprehensive database that includes medical records of both parents and newborns to collect biological samples, questionnaires, and health data. By analyzing this information, the study aims to provide valuable insights into the health prognosis of these children, which has been largely unknown until now.

Why it matters

Potential benefit: If successful, this study could provide critical information on the health outcomes of newborns conceived through ART, guiding future medical care and parental counseling.

How similar studies have gone: While there have been studies on ART outcomes, this specific cohort analysis focusing on long-term health consequences in newborns is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All newborns from patients treated with ART in our center.

Exclusion Criteria:

\-

Where it's running

  • Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University
    Zhengzhou, Henan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.